review Open AccessTop 1% cited
The T cell immune response against SARS-CoV-2
Nature Immunology · 2022 · Vol. 23(2) · pp. 186–193
Paul Moss✉(University of Birmingham)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Immune systemImmunologyBiologyImmunityT cellDiseaseAcquired immune systemHeterologousVirologyMedicine
MeSH terms
COVID-19SARS-CoV-2AnimalsAntigens, ViralCross ReactionsHumansImmunity, CellularImmunologic MemoryLymphocyte ActivationPhenotypeT-LymphocytesHost-Pathogen Interactions
Citations
1,295
FWCI
126.09
field-weighted impact
References
141
Percentile
100%
vs. same field & year
Citations per year
References
Clinical and immunological features of severe and moderate coronavirus disease 2019
Journal of Clinical Investigation · 2020 · 5,044 citations
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Cell · 2020 · 4,475 citations
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Frontiers in Immunology · 2020 · 2,506 citations
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Nature Structural & Molecular Biology · 2020 · 619 citations
Dexamethasone in Hospitalized Patients with Covid-19
New England Journal of Medicine · 2020 · 9,985 citations
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Nature Medicine · 2021 · 4,152 citations
Evidence for antibody as a protective correlate for COVID-19 vaccines
Vaccine · 2021 · 969 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.